| Alla Rudinskaya, MD | |
|
41 Germantown Rd, Danbury, CT 06810-4087 | |
| (203) 207-3320 | |
| Not Available |
| Full Name | Alla Rudinskaya |
|---|---|
| Gender | Female |
| Speciality | Rheumatology |
| Experience | 34 Years |
| Location | 41 Germantown Rd, Danbury, Connecticut |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891710612 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | 039540 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Danbury Hospital | Danbury, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Danbury Hospital | 1557273935 | 35 |
| Nuvance Health Medical Practice Ct Inc | 4789597691 | 648 |
News Archive
Dana-Farber/Boston Children's Cancer and Blood Disorders Center has joined a clinical trial of immunotherapy for children with relapsed or treatment-resistant acute lymphoblastic leukemia (ALL). Led by Memorial Sloan Kettering Cancer Center, the trial is one of several nationally that are evaluating cancer immunotherapy, a treatment approach - hailed by Science magazine as their Breakthrough of the Year in 2013 - that triggers a patient's immune system to attack his or her cancer cells.
Consumption of high-fat yoghurt and cheese are linked to a reduction in the risk of type 2 diabetes by as much as a fifth, according to new research from Lund University in Sweden. High meat consumption, on the other hand, is linked to a higher risk.
An updated American Cancer Society guideline says colorectal cancer screening should begin at age 45 for people at average risk, based in part on data showing rates of colorectal cancer are increasing in young and middle-aged populations.
Following the global and joint initiative by the pharmaceutical, biotechnology and diagnostics industries this year to combat antibiotic resistance, demand for innovative solutions is especially high. The event took place in January at the World Economic Forum in Davos.
In December 1995, a highly controversial trial was published, which tested a clot-busting drug called rt-PA (recombinant tissue plasminogen activator) in patients who had suffered an acute stroke.
› Verified 4 days ago
| Entity Name | Danbury Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548293343 PECOS PAC ID: 1557273935 Enrollment ID: O20031104000476 |
News Archive
Dana-Farber/Boston Children's Cancer and Blood Disorders Center has joined a clinical trial of immunotherapy for children with relapsed or treatment-resistant acute lymphoblastic leukemia (ALL). Led by Memorial Sloan Kettering Cancer Center, the trial is one of several nationally that are evaluating cancer immunotherapy, a treatment approach - hailed by Science magazine as their Breakthrough of the Year in 2013 - that triggers a patient's immune system to attack his or her cancer cells.
Consumption of high-fat yoghurt and cheese are linked to a reduction in the risk of type 2 diabetes by as much as a fifth, according to new research from Lund University in Sweden. High meat consumption, on the other hand, is linked to a higher risk.
An updated American Cancer Society guideline says colorectal cancer screening should begin at age 45 for people at average risk, based in part on data showing rates of colorectal cancer are increasing in young and middle-aged populations.
Following the global and joint initiative by the pharmaceutical, biotechnology and diagnostics industries this year to combat antibiotic resistance, demand for innovative solutions is especially high. The event took place in January at the World Economic Forum in Davos.
In December 1995, a highly controversial trial was published, which tested a clot-busting drug called rt-PA (recombinant tissue plasminogen activator) in patients who had suffered an acute stroke.
› Verified 4 days ago
| Entity Name | Nuvance Health Medical Practice Ct Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407898117 PECOS PAC ID: 4789597691 Enrollment ID: O20031205000130 |
News Archive
Dana-Farber/Boston Children's Cancer and Blood Disorders Center has joined a clinical trial of immunotherapy for children with relapsed or treatment-resistant acute lymphoblastic leukemia (ALL). Led by Memorial Sloan Kettering Cancer Center, the trial is one of several nationally that are evaluating cancer immunotherapy, a treatment approach - hailed by Science magazine as their Breakthrough of the Year in 2013 - that triggers a patient's immune system to attack his or her cancer cells.
Consumption of high-fat yoghurt and cheese are linked to a reduction in the risk of type 2 diabetes by as much as a fifth, according to new research from Lund University in Sweden. High meat consumption, on the other hand, is linked to a higher risk.
An updated American Cancer Society guideline says colorectal cancer screening should begin at age 45 for people at average risk, based in part on data showing rates of colorectal cancer are increasing in young and middle-aged populations.
Following the global and joint initiative by the pharmaceutical, biotechnology and diagnostics industries this year to combat antibiotic resistance, demand for innovative solutions is especially high. The event took place in January at the World Economic Forum in Davos.
In December 1995, a highly controversial trial was published, which tested a clot-busting drug called rt-PA (recombinant tissue plasminogen activator) in patients who had suffered an acute stroke.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Alla Rudinskaya, MD 41 Germantown Rd, Danbury, CT 06810-4087 Ph: (203) 207-3320 | Alla Rudinskaya, MD 41 Germantown Rd, Danbury, CT 06810-4087 Ph: (203) 207-3320 |
News Archive
Dana-Farber/Boston Children's Cancer and Blood Disorders Center has joined a clinical trial of immunotherapy for children with relapsed or treatment-resistant acute lymphoblastic leukemia (ALL). Led by Memorial Sloan Kettering Cancer Center, the trial is one of several nationally that are evaluating cancer immunotherapy, a treatment approach - hailed by Science magazine as their Breakthrough of the Year in 2013 - that triggers a patient's immune system to attack his or her cancer cells.
Consumption of high-fat yoghurt and cheese are linked to a reduction in the risk of type 2 diabetes by as much as a fifth, according to new research from Lund University in Sweden. High meat consumption, on the other hand, is linked to a higher risk.
An updated American Cancer Society guideline says colorectal cancer screening should begin at age 45 for people at average risk, based in part on data showing rates of colorectal cancer are increasing in young and middle-aged populations.
Following the global and joint initiative by the pharmaceutical, biotechnology and diagnostics industries this year to combat antibiotic resistance, demand for innovative solutions is especially high. The event took place in January at the World Economic Forum in Davos.
In December 1995, a highly controversial trial was published, which tested a clot-busting drug called rt-PA (recombinant tissue plasminogen activator) in patients who had suffered an acute stroke.
› Verified 4 days ago
Dr. Shivayogi V Magavi, MD Rheumatology Medicare: May Accept Medicare Assignments Practice Location: 57 North St, Suite 103, Danbury, CT 06810 Phone: 203-744-7007 | |
Andrew Keller, M.D. Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 27 Hospital Ave, Danbury, CT 06810 Phone: 203-797-7155 | |
Mary E. Blackman, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 79 Sand Pit Road, 102, Danbury, CT 06810 Phone: 203-749-5700 | |
Nirmalamma S Magavi, MD Rheumatology Medicare: May Accept Medicare Assignments Practice Location: 57 North St, Suite 103, Danbury, CT 06810 Phone: 203-744-7007 | |
David D Weinshel, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 24 Hospital Ave, Danbury, CT 06810 Phone: 203-797-7173 | |
Dr. Michael Spiegel, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 33 Germantown Rd, 1st Floor, Danbury, CT 06810 Phone: 203-794-5600 Fax: 203-794-5611 | |
Michael Cohenuram, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 24 Hospital Ave, Danbury, CT 06810 Phone: 203-797-7742 Fax: 203-830-2090 |